Literature DB >> 25533036

How I treat incidental pulmonary embolism.

Casey O'Connell1.   

Abstract

The identification of pulmonary embolism (PE) on computed tomography scans performed for indications other than identification of thromboembolism is a growing clinical problem that has not been adequately addressed by prospective treatment trials. The prevalence of incidentally detected PE ranges from 1% to 4% in unselected populations, with higher rates among hospital inpatients and patients with cancer. Current guidelines recommend using the same approach to type and duration of anticoagulation as is used for patients with suspected PE. Available data regarding the significance of symptomatic subsegmental PE (SSPE) are conflicting, making it difficult to draw conclusions about the appropriate treatment of incidentally detected SSPE, for which the data are sparse. Among cancer patients, the bulk of available data suggest that incidental SSPE is associated with recurrent venous thromboembolism and, when symptomatic, may adversely impact survival. Here, the topic is reviewed utilizing 3 clinical cases, each of which is followed by a discussion of salient features and then by treatment recommendations.
© 2015 by The American Society of Hematology.

Entities:  

Mesh:

Year:  2014        PMID: 25533036     DOI: 10.1182/blood-2014-08-551879

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

1.  Incidental pulmonary embolism in suspected stroke patients undergoing carotid CT angiography.

Authors:  Guang-Liang Chen; Dong-Hui Shen; Jin Wei; Hua Wang; Yuan-Fen Liu; Qing Duan
Journal:  Radiol Med       Date:  2018-02-09       Impact factor: 3.469

2.  Management of venous thromboembolism during thrombocytopenia after autologous hematopoietic cell transplantation.

Authors:  Ang Li; Chris Davis; Qian Wu; Shan Li; Madeline F Kesten; Leona A Holmberg; Ajay K Gopal; David A Garcia
Journal:  Blood Adv       Date:  2017-04-27

Review 3.  Risk stratification and management of acute pulmonary embolism.

Authors:  Cecilia Becattini; Giancarlo Agnelli
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

Review 4.  Cancer-associated venous thromboembolism.

Authors:  Alok A Khorana; Nigel Mackman; Anna Falanga; Ingrid Pabinger; Simon Noble; Walter Ageno; Florian Moik; Agnes Y Y Lee
Journal:  Nat Rev Dis Primers       Date:  2022-02-17       Impact factor: 65.038

Review 5.  Management of Acute Pulmonary Embolism.

Authors:  Connor Tice; Matthew Seigerman; Paul Fiorilli; Steven C Pugliese; Sameer Khandhar; Jay Giri; Taisei Kobayashi
Journal:  Curr Cardiovasc Risk Rep       Date:  2020-10-06

6.  Direct Oral Anticoagulants and Cancer Thrombosis: What APs Need to Know.

Authors:  Mailey L Wilks
Journal:  J Adv Pract Oncol       Date:  2022-05-23

7.  Apatinib to combat EGFR-TKI resistance in an advanced non-small cell lung cancer patient with unknown EGFR status: a case report.

Authors:  Yanmei Peng; Huijuan Cui; Zhe Liu; Daiwei Liu; Fan Liu; Yazhong Song; Hua Duan; Yuqin Qiu; Qiang Li
Journal:  Onco Targets Ther       Date:  2017-04-26       Impact factor: 4.147

8.  The incidence of acute pulmonary embolism following syncope in anticoagulant-naïve patients: A retrospective cohort study.

Authors:  Danny Epstein; Gidon Berger; Noam Barda; Erez Marcusohn; Yuval Barak-Corren; Khitam Muhsen; Ran D Balicer; Zaher S Azzam
Journal:  PLoS One       Date:  2018-03-07       Impact factor: 3.240

9.  Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome Associated with Risk of Pulmonary Embolism.

Authors:  Jun-Jun Yeh; Yu-Chiao Wang; Chia-Hung Kao
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.